IRIS UniCatt

Galli, Eugenio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.354
EU - Europa 2.194
AS - Asia 2.152
SA - Sud America 404
Continente sconosciuto - Info sul continente non disponibili 139
AF - Africa 57
OC - Oceania 1
Totale 8.301
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.216
SG - Singapore 914
IT - Italia 502
CN - Cina 480
DE - Germania 370
NL - Olanda 360
BR - Brasile 331
VN - Vietnam 249
FR - Francia 172
FI - Finlandia 170
SE - Svezia 170
PL - Polonia 152
IN - India 102
GB - Regno Unito 91
JP - Giappone 73
CA - Canada 71
BD - Bangladesh 70
ID - Indonesia 47
IE - Irlanda 47
HK - Hong Kong 42
KR - Corea 40
MX - Messico 33
RU - Federazione Russa 32
AT - Austria 23
CZ - Repubblica Ceca 23
AR - Argentina 21
ES - Italia 21
IQ - Iraq 19
SA - Arabia Saudita 17
TR - Turchia 15
EC - Ecuador 14
BE - Belgio 13
CO - Colombia 13
CI - Costa d'Avorio 11
UZ - Uzbekistan 11
VE - Venezuela 11
ZA - Sudafrica 11
KE - Kenya 9
UA - Ucraina 9
JO - Giordania 8
MA - Marocco 8
IL - Israele 7
LT - Lituania 7
PK - Pakistan 7
NP - Nepal 6
IR - Iran 5
AZ - Azerbaigian 4
GT - Guatemala 4
KZ - Kazakistan 4
LB - Libano 4
RO - Romania 4
TN - Tunisia 4
UY - Uruguay 4
BO - Bolivia 3
BY - Bielorussia 3
CL - Cile 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
OM - Oman 3
PH - Filippine 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BS - Bahamas 2
BZ - Belize 2
CH - Svizzera 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
IS - Islanda 2
JM - Giamaica 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
MY - Malesia 2
PR - Porto Rico 2
PY - Paraguay 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 8.151
Salva come PNG Salva come JPEG
Città #
Singapore 521
San Jose 441
Amsterdam 348
Ashburn 335
Rome 156
Munich 152
Frankfurt am Main 148
Warsaw 145
Los Angeles 137
Chandler 119
Council Bluffs 108
Hefei 107
Helsinki 102
Beijing 93
New York 81
Chicago 77
St Louis 76
Tokyo 72
Hanoi 70
Milan 70
The Dalles 67
Lauterbourg 65
Ho Chi Minh City 64
Hyderabad 57
Santa Clara 48
Dallas 43
Dublin 42
Hong Kong 40
Seoul 40
Florence 35
Jakarta 35
Phoenix 35
Kent 34
Lappeenranta 33
Fairfield 31
Atlanta 30
London 28
Turku 27
Brooklyn 25
Orem 23
Montreal 22
Seattle 22
Toronto 22
Paris 21
São Paulo 20
Denver 19
Houston 19
Nuremberg 19
Boardman 18
Buffalo 18
Da Nang 16
Brno 15
Chennai 15
Miami 15
Moscow 15
Wilmington 15
Marseille 14
Boston 13
Bremen 13
Brussels 13
Mexico City 13
Woodbridge 13
Belo Horizonte 12
Charlotte 12
Düsseldorf 12
Abidjan 11
Naples 11
Princeton 11
San Francisco 11
Tashkent 11
Rio de Janeiro 10
San Mateo 10
Stockholm 10
Vienna 10
Haiphong 9
Manchester 9
Poplar 9
Redmond 9
Campinas 8
Falls Church 8
Guangzhou 8
Nairobi 8
Philadelphia 8
Tampa 8
Amman 7
Baghdad 7
Catania 7
Curitiba 7
Jacksonville 7
Johannesburg 7
Palermo 7
Shanghai 7
Tukwila 7
Washington 7
Bogotá 6
Brasília 6
Cambridge 6
Casablanca 6
Cattolica 6
Jeddah 6
Totale 4.851
Salva come PNG Salva come JPEG
Nome #
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 650
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 310
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 298
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 288
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 259
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 245
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 195
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 163
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 163
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 159
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 152
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 150
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 139
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 136
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 136
CAR-T treatment is safe and effective in adult patients with Down syndrome and B-cell acute lymphoblastic leukemia (B-ALL) 132
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 131
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 127
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 126
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 126
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 126
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 124
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 124
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 124
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 124
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 119
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 118
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 117
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 117
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 116
Coagulopathy in CAR-T: Critical concern or mere blip? 116
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 114
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma 113
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 111
Baseline Tumor Burden Assessed With AI-Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR-T in Aggressive B-Cell Lymphoma 110
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 109
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 107
Vascular inflammation in patients undergoing anti-CD19 chimeric antigen receptor-T cells for haematologic malignancies: a call for cardiovascular surveillance 106
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 104
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 104
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 97
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 96
VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation 95
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 91
Prognostic factors in hodgkin lymphoma 90
G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma 89
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT 87
Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant 83
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 80
Cinnamon-enriched chocolate pralines as a delivery system for Lacticaseibacillus rhamnosus CRL1505: viability and digestive stability 80
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma 78
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 75
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 72
Predicting therapy-related myeloid neoplasms after CAR-T with the Clonal Haematopoiesis Risk Score (CHRS) 70
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 69
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study 58
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? 57
Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T 57
is allogenic transplantation on option in patients affected by concurrent myelofibrosis and chronia myeloid leukemia (CML) 55
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 50
Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy 50
Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy 46
Frail is not fail: Limited impact of comorbidities on non‐relapse mortality and safety in patients with LBCL treated with CAR‐T 45
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 38
Clinical features and management of LICATS involving the heart in a patient with diffuse and rapidly progressive systemic sclerosis 32
Neuronal injury biomarkers GFAP and neurofilament light chains (NfL) are associated with neurotoxicity and endothelial dysfunction in adult patients treated with antiCD19 CART cells 30
Organ-specific local cytokine release syndrome after anti-CD19 CAR-T therapy with salivary gland involvement: a case report, literature review, and a diagnostic alert for tocilizumab-associated cervical swelling 28
Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a Real-World Setting 23
Platelet recovery delay and survival in patients with myelofibrosis undergoing allogeneic hemopoietic stem cell transplantation 21
Deciphering the Complex Intertwining Between Cytopenia and Transfusion Needs After CAR-T-Cell Therapy for B-Cell Malignancies 20
Lymphodepletion and donor lymphocyte infusions (LD-DLI) for DLI-non responsive myelofibrosis 18
Rationale and Design of the CARdio-Tox Study: A Prospective Evaluation of Cardiovascular Toxicity in Patients Receiving Chimeric Antigen Receptor-T (CAR-T) Cell Therapy 13
Tracking inflammation in CAR-T therapy: the emerging role of serum amyloid A (SAA) 10
High-dose thiotepa may induce inappropriate secretion of antidiuretic hormone syndrome (SIADH) during conditioning treatment for allogeneic stem cell transplantation 10
Totale 8.301
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.953
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022109 0 0 0 5 13 8 2 14 6 5 24 32
2022/2023427 67 47 16 63 28 52 34 27 47 21 23 2
2023/2024398 10 71 26 39 5 50 28 38 5 35 34 57
2024/20251.768 41 30 78 169 111 95 123 79 184 165 420 273
2025/20263.860 420 139 214 335 463 642 556 200 269 312 151 159
2026/20271.420 326 521 281 292 0 0 0 0 0 0 0 0
Totale 8.301